Cost-sharing ranging from 0% and 100% according to drug category (drugs of high therapeutic value used in the treatment of severe diseases –diabetes, cancer- are free of charge but patients must pay cost-sharing for other categories); patient status (preferential or not) and ex-factory price of the drug. Cost-sharing per item is capped for important drugs (e.g. antibiotics, cardiovascular).